Inventabio

Inventabio is a Switzerland-registered entity, established on 20 April 2023, operating under the domain inventabio.org. The company lists its registered address at Av. de Morges 28, 1004 Lausanne. Based on publicly available records, the broker does not hold any known regulatory licences from financial authorities.

Switzerland is home to a well-regarded financial regulator, FINMA, but Inventabio does not appear on FINMA's register of authorised firms. The absence of a licence from any reputable regulatory body is a significant factor for traders to consider, as it means the broker is not subject to the oversight and investor protection frameworks that licensed brokers must adhere to.

FXCanary's independent research has assigned Inventabio a Scam Risk Score of 49 out of 100, placing it in the 'Guarded' category. This score reflects the lack of verifiable regulatory oversight and the limited independent information available about the broker's operations.

Traders should exercise caution when dealing with unregulated brokers. Without a licence, investors have no recourse to a financial ombudsman or compensation scheme if disputes arise. The guarded score indicates that while there is no immediate evidence of fraud, the absence of transparency and regulatory safeguards elevates the risk profile.

The company's Swiss registration provides a degree of corporate transparency, as Swiss company records are publicly accessible. However, registration as a commercial entity does not equate to authorisation to offer financial services. Inventabio's official domain, inventabio.org, provides limited public information about its services.

Our review found no evidence of the broker publishing audited financial statements, details of its management team, or client fund segregation policies. Such a lack of transparency is a common characteristic among high-risk or unregulated brokers and warrants further due diligence by prospective clients.